Japan greenlights clinical tests on donor iPS cell transplants

Alternative treatment seen slashing cost, time

Researchers are optimistic that iPS cells will play a major role in regenerative medicine.

February 2, 2017 06:50 JST | Japan

TOKYO -- The Japanese health ministry on Wednesday approved clinical research on a regenerative treatment that utilizes donated stem cells.

Sponsored Content